...
search icon
cmnd-img

Clearmind Medicine Inc. Common Shares, Common Stock

CMND

NAQ

$0.965

-$0.04

(-4%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$5.08M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
24.82K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-1.36
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.85 L
$2.3 H
$0.965

About Clearmind Medicine Inc. Common Shares, Common Stock

Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. The company develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, it has a collaboration with SciSparc Ltd. to conduct a study evaluating the companies combination treatment for obesity and metabolic syndrome; Yissum Research Development Company of the Hebrew University of Jerusalem to develop, manufacture, and commercialize compounds targeted at treating post traumatic stress disorder and other health conditions. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is based in Vancouver, Canada. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameCMNDSectorS&P500
1-Week Return-2.53%-1.91%-1.87%
1-Month Return-1.17%-3.82%8.93%
3-Month Return-22.49%-11.56%-2.39%
6-Month Return-27.44%-10.21%-2.41%
1-Year Return-14.22%-9.91%10.88%
3-Year Return-99.64%-0.28%46.93%
5-Year Return-99.85%31.29%94.89%

Financials

Oct '20Oct '21Oct '22Oct '23Oct '245YR TREND
Total Revenue-----[{"date":"2020-10-31","value":"-","profit":true},{"date":"2021-10-31","value":"-","profit":true},{"date":"2022-10-31","value":"-","profit":true},{"date":"2023-10-31","value":"-","profit":true},{"date":"2024-10-31","value":"-","profit":true}]
Cost of Revenue-2.57K113.38K56.34K26.70K[{"date":"2020-10-31","value":"-","profit":true},{"date":"2021-10-31","value":2.27,"profit":true},{"date":"2022-10-31","value":100,"profit":true},{"date":"2023-10-31","value":49.69,"profit":true},{"date":"2024-10-31","value":23.55,"profit":true}]
Gross Profit-(2.57K)(113.38K)(56.34K)(26.70K)[{"date":"2020-10-31","value":"-","profit":true},{"date":"2021-10-31","value":-257200,"profit":false},{"date":"2022-10-31","value":-11337900,"profit":false},{"date":"2023-10-31","value":-5634200,"profit":false},{"date":"2024-10-31","value":-2670300,"profit":false}]
Gross Margin-(Infinity%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2020-10-31","value":"-","profit":true},{"date":"2021-10-31","value":null,"profit":false},{"date":"2022-10-31","value":null,"profit":false},{"date":"2023-10-31","value":null,"profit":false},{"date":"2024-10-31","value":null,"profit":false}]
Operating Expenses233.22K3.68M8.53M8.74M5.72M[{"date":"2020-10-31","value":2.67,"profit":true},{"date":"2021-10-31","value":42.06,"profit":true},{"date":"2022-10-31","value":97.61,"profit":true},{"date":"2023-10-31","value":100,"profit":true},{"date":"2024-10-31","value":65.42,"profit":true}]
Operating Income(233.22K)(3.45M)(8.53M)(8.74M)(6.30M)[{"date":"2020-10-31","value":-23322000,"profit":false},{"date":"2021-10-31","value":-345299800,"profit":false},{"date":"2022-10-31","value":-853257900,"profit":false},{"date":"2023-10-31","value":-874135013,"profit":false},{"date":"2024-10-31","value":-630012900,"profit":false}]
Total Non-Operating Income/Expense(233.22K)(43.53K)(855.54K)(3.13M)1.26M[{"date":"2020-10-31","value":-18.5,"profit":false},{"date":"2021-10-31","value":-3.45,"profit":false},{"date":"2022-10-31","value":-67.88,"profit":false},{"date":"2023-10-31","value":-248.37,"profit":false},{"date":"2024-10-31","value":100,"profit":true}]
Pre-Tax Income(233.22K)(3.90M)(9.37M)(11.93M)(4.88M)[{"date":"2020-10-31","value":-23322000,"profit":false},{"date":"2021-10-31","value":-389943400,"profit":false},{"date":"2022-10-31","value":-937005200,"profit":false},{"date":"2023-10-31","value":-1193094100,"profit":false},{"date":"2024-10-31","value":-487671200,"profit":false}]
Income Taxes(385.99K)223.22K40.75K24.09K377.97K[{"date":"2020-10-31","value":-102.12,"profit":false},{"date":"2021-10-31","value":59.06,"profit":true},{"date":"2022-10-31","value":10.78,"profit":true},{"date":"2023-10-31","value":6.37,"profit":true},{"date":"2024-10-31","value":100,"profit":true}]
Income After Taxes152.77K(4.12M)(9.41M)(11.96M)(5.25M)[{"date":"2020-10-31","value":100,"profit":true},{"date":"2021-10-31","value":-2698.67,"profit":false},{"date":"2022-10-31","value":-6160.28,"profit":false},{"date":"2023-10-31","value":-7825.71,"profit":false},{"date":"2024-10-31","value":-3439.69,"profit":false}]
Income From Continuous Operations(233.22K)(3.90M)(9.41M)(8.62M)(5.25M)[{"date":"2020-10-31","value":-23322000,"profit":false},{"date":"2021-10-31","value":-389943400,"profit":false},{"date":"2022-10-31","value":-941080600,"profit":false},{"date":"2023-10-31","value":-862083700,"profit":false},{"date":"2024-10-31","value":-525467800,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-10-31","value":"-","profit":true},{"date":"2021-10-31","value":"-","profit":true},{"date":"2022-10-31","value":"-","profit":true},{"date":"2023-10-31","value":"-","profit":true},{"date":"2024-10-31","value":"-","profit":true}]
Net Income(233.22K)(4.12M)(9.41M)(11.96M)(5.25M)[{"date":"2020-10-31","value":-23322000,"profit":false},{"date":"2021-10-31","value":-412265200,"profit":false},{"date":"2022-10-31","value":-941080600,"profit":false},{"date":"2023-10-31","value":-1195503100,"profit":false},{"date":"2024-10-31","value":-525467800,"profit":false}]
EPS (Diluted)-(48.26)(168.98)(54.31)(1.98)[{"date":"2020-10-31","value":"-","profit":true},{"date":"2021-10-31","value":-4825.63,"profit":false},{"date":"2022-10-31","value":-16898.35,"profit":false},{"date":"2023-10-31","value":-5431.22,"profit":false},{"date":"2024-10-31","value":-197.62,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CMND
Cash Ratio 1.59
Current Ratio 1.72

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CMND
ROA (LTM) -43.89%
ROE (LTM) -125.61%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CMND
Debt Ratio Lower is generally better. Negative is bad. 0.57
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.43

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CMND
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 1.74
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Clearmind Medicine Inc. Common Shares share price today?

Clearmind Medicine Inc. Common Shares (CMND) share price today is $0.965

Can Indians buy Clearmind Medicine Inc. Common Shares shares?

Yes, Indians can buy shares of Clearmind Medicine Inc. Common Shares (CMND) on Vested. To buy Clearmind Medicine Inc. Common Shares from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CMND stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Clearmind Medicine Inc. Common Shares be purchased?

Yes, you can purchase fractional shares of Clearmind Medicine Inc. Common Shares (CMND) via the Vested app. You can start investing in Clearmind Medicine Inc. Common Shares (CMND) with a minimum investment of $1.

How to invest in Clearmind Medicine Inc. Common Shares shares from India?

You can invest in shares of Clearmind Medicine Inc. Common Shares (CMND) via Vested in three simple steps:

  • Click on Sign Up or Invest in CMND stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Clearmind Medicine Inc. Common Shares shares
What is Clearmind Medicine Inc. Common Shares 52-week high and low stock price?

The 52-week high price of Clearmind Medicine Inc. Common Shares (CMND) is $2.3. The 52-week low price of Clearmind Medicine Inc. Common Shares (CMND) is $0.85.

What is Clearmind Medicine Inc. Common Shares price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Clearmind Medicine Inc. Common Shares (CMND) is 1.74

What is the Market Cap of Clearmind Medicine Inc. Common Shares?

The market capitalization of Clearmind Medicine Inc. Common Shares (CMND) is $5.08M

What is Clearmind Medicine Inc. Common Shares’s stock symbol?

The stock symbol (or ticker) of Clearmind Medicine Inc. Common Shares is CMND

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top